Table 4. Summary of findings and GRADE quality assessment of primary and secondary outcomes for Comparison 3: comparing clomiphene citrate plus LC versus clomiphene citrate plus n acetylcysteine.
Certainty assessment | Number of patients | Effect | Certainty | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Total study | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | LC+CC | CC + NAC | Relative (95% CI) | Absolute (95% CI) | |
Outcome: Clinical pregnancy rate | ||||||||||
1 RCT | not serious | not serious | not serious | seriousa | none | 25/80 (31.3%) | 22/82 (26.8%) | RR 1.16 (0.72 to 1.89) | 43 more per 1,000 (from 75 fewer to 239 more) | MODERATE |
Outcome: Ovulation rate | ||||||||||
1 RCT | not serious | not serious | not serious | seriousa | none | 38/80 (47.5%) | 35/82 (42.7%) | RR 1.11 (0.79 to 1.56) | 47 more per 1,000 (from 90 fewer to 239 more) | MODERATE |
Outcome: BMI | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 0.1 higher (0.78 lower to 0.98 higher) | MODERATE |
Outcome: Serum FPG | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 2.3 higher (1.02 higher to 3.58 higher) | MODERATE |
Outcome: serum LDL | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 12 lower (15.8 lower to 8.2 lower) | MODERATE |
Outcome: serum total cholesterol | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 24 lower (27.61 lower to 20.39 lower) | MODERATE |
Outcome: serum HDL | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 9.6 higher (5.3 higher to 13.9 higher) | MODERATE |
Outcome: serum triglyceride | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 19 lower (22.79 lower to 15.21 lower) | MODERATE |
Outcome: serum FSH | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 0.5 lower (0.84 lower to 0.16 lower) | MODERATE |
Outcome: serum LH | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 80 | 82 | – | MD 0.4 lower (1.51 lower to 0.71 higher) | MODERATE |
Notes.
- CI
- Confidence interval
- RR
- Risk ratio
- MD
- Mean difference
- RCT
- Randomized controlled trial
- GRADE
- Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.
Explanations
number of events <400.
number of participants <400.